Novavax, Inc. - Common Stock (NQ:NVAX)

12.56 +2.10 (+20.08%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

68 69 Next >

Why Moderna Stock Dropped Today ↗

October 19, 2022

Competition is intensifying.

Via The Motley Fool

Why Novavax Stock Couldn't Win on Wednesday ↗

October 19, 2022

FDA authorization isn't necessarily a slam dunk for a company.

Via The Motley Fool

Why Novavax's Uphill Battle Continues Despite Winning U.S. Booster Authorization ↗

October 19, 2022

Novavax's booster could be used by half of U.S. adults. But, will it?

Via Investor's Business Daily

FDA Gives Emergency Nod To Novavax's Adjuvanted COVID-19 Booster Dose ↗

October 19, 2022

Via Benzinga

What's Going On With Novavax Shares Spiking Higher Today ↗

October 19, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 1.60% to $18.92 Wednesday morning. The FDA granted Emergency Use Authorization for the company's COVID-19 vaccine as a booster for adults after...

Via Benzinga

More Likely to Double First: Teladoc or Novavax? ↗

October 19, 2022

Both stocks soared during the early days of the pandemic.

Via The Motley Fool

Why Novavax Stock Is Skyrocketing This Week ↗

October 13, 2022

The vaccine maker had a flurry of good news.

Via The Motley Fool

Why Novavax Stock Is Jumping Today ↗

October 10, 2022

The company reported positive developments in Switzerland and South Korea.

Via The Motley Fool

A Shot of NVAX Stock Is NOT What Your Portfolio Needs ↗

September 28, 2022

Even before Biden's 'pandemic is over' declaration, NVAX stock struggled due to weak demand for Novavax's Covid-19 shots.

Via InvestorPlace

Why BioNTech SE And Novavax Shares Are Diving ↗

October 18, 2022

BioNTech SE - ADR (NASDAQ: BNTX) and Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 4.07% to $133.28 and 7.68% to $18.76, respectively, ahead of the close of Tuesday's session. Vaccine stock

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Got $300? 3 Genius Stocks to Buy on the Dip ↗

October 18, 2022

You don't need a boatload of cash to begin building wealth on Wall Street.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 17, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022? ↗

October 16, 2022

These four tech stocks are down nearly 90%.

Via The Motley Fool

Why Novavax Stock Had an Ugly Friday ↗

October 14, 2022

Investors ding the biotech's shares one day after it reported quite good news about an experimental vaccine.

Via The Motley Fool

Microsoft To $325? Plus This Analyst Sees BlackRock Dropping By 15% ↗

October 14, 2022

Morgan Stanley lowered the price target on Microsoft Corporation (NASDAQ: MSFT) from $354 to $325. Microsoft shares fell 0.3% to $233.50 in pre-market trading.

Via Benzinga

What's Going On With Novavax Shares? ↗

October 12, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 6.80% to $20.26 going into the close of Wednesday's trading session after the company reported the results from its Phase 3 PREVENT-19 trial...

Via Benzinga

KnowBe4 (KNBE) Stock Jumps 12% on Take-Private Deal ↗

October 12, 2022

KnowBe4 (KNBE) stock is getting a boost on Wednesday as investors react to a deal that will take the cybersecurity company private.

Via InvestorPlace

Novavax Prototype COVID-19 Vaccine Data Shows Benefit Against Variants ↗

October 12, 2022

Novavax Inc (NASDAQ: NVAX) presented data from the Phase 3 PREVENT-19 trial and Study 307 (Lot Consistency) at the World Vaccine Congress Europe 2022.

Via Benzinga

Why Is Novavax (NVAX) Stock in the Spotlight Today? ↗

October 12, 2022

Novavax (NVAX) stock is on the move Wednesday following positive data from its Phase 3 PREVENT-19 vaccine trial and Study 307.

Via InvestorPlace

Is Pfizer Stock Still Worth Buying After the Pandemic?

October 12, 2022

Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations.

Via MarketBeat

5 Investors Betting Big on Novavax (NVAX) Stock ↗

October 11, 2022

NVAX stock is in focus as the company receives a recommendation from the Swiss health agency concerning its Nuvaxovid drug.

Via InvestorPlace

Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway ↗

October 11, 2022

Today, investors in Novavax and NVAX stock are cheering the start of a major conference on vaccine tech, which Novavax is a part of.

Via InvestorPlace

What's Going On With Novavax Shares? ↗

October 11, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 11.4% to $19.80 Tuesday afternoon ahead of the company's presentation of data at the World Vaccine Congress Europe 2022 this week. What Else?

Via Benzinga

Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down' ↗

October 11, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said BlackBerry Limited (NYSE: BB) is losing money and he's been "against them the whole way down."

Via Benzinga

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11 ↗

October 10, 2022

Shares of NVAX stock are climbing ahead of the World Vaccine Congress Europe 2022, where Novavax will share new vaccine data.

Via InvestorPlace

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session ↗

October 10, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...

Via Benzinga

Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday ↗

October 10, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Monday. Here are some big stocks recording gained in today’s session.

Via Benzinga

Swiss Health Agency Approves Pfizer, Novavax's Omicron Adapted COVID-19 Boosters ↗

October 10, 2022

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.